Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication.
D000628:Aminophylline / Q000494:pharmacology; D000818:Animals; D001809:Blood Viscosity / Q000187:drug effects; D003692:Delayed-Action Preparations; D004347:Drug Interactions; D004912:Erythrocytes / Q000187:drug effects; D005260:Female; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy*; D007700:Kinetics; D010431:Pentoxifylline / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D010949:Plasma / Q000032:analysis; D011247:Pregnancy; D012039:Regional Blood Flow / Q000187:drug effects; D012212:Rheology; D013805:Theobromine / Q000031:analogs & derivatives*
D003692:Delayed-Action Preparations; D000628:Aminophylline; D013805:Theobromine; D010431:Pentoxifylline